Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation.
This report aims to provide a comprehensive presentation of the global market for Organ Transplant Immunosuppressant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Transplant Immunosuppressant Drugs. This report contains market size and forecasts of Organ Transplant Immunosuppressant Drugs in global, including the following market information:
Global Organ Transplant Immunosuppressant Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Organ Transplant Immunosuppressant Drugs Market Sales, 2018-2023, 2024-2029, (K Doses)
Global top five Organ Transplant Immunosuppressant Drugs companies in 2022 (%)
The global Organ Transplant Immunosuppressant Drugs market was valued at US$ 5249.7 million in 2022 and is projected to reach US$ 6500.7 million by 2029, at a CAGR of 3.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Organ Transplant Immunosuppressant Drugs include Roche, Sanofi, Astellas Pharma, Inc., GlaxoSmithKline plc, Novartis AG, Pfizer, Inc. and Veloxis Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Organ Transplant Immunosuppressant Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Organ Transplant Immunosuppressant Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Organ Transplant Immunosuppressant Drugs Market Segment Percentages, by Type, 2022 (%)
- Antibodies
- Antiproliferative Agents
- Calcineurin Inhibitors
- mTOR Inhibitors
- Steroids
Global Organ Transplant Immunosuppressant Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Organ Transplant Immunosuppressant Drugs Market Segment Percentages, by Application, 2022 (%)
- Bone Marrow Transplant
- Heart Transplant
- Kidney Transplant
- Liver Transplant
- Lung Transplant
Global Organ Transplant Immunosuppressant Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Organ Transplant Immunosuppressant Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Organ Transplant Immunosuppressant Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Organ Transplant Immunosuppressant Drugs revenues share in global market, 2022 (%)
Key companies Organ Transplant Immunosuppressant Drugs sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Organ Transplant Immunosuppressant Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- Sanofi
- Astellas Pharma, Inc.
- GlaxoSmithKline plc
- Novartis AG
- Pfizer, Inc.
- Veloxis Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Organ Transplant Immunosuppressant Drugs, market overview.
Chapter 2: Global Organ Transplant Immunosuppressant Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Organ Transplant Immunosuppressant Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Organ Transplant Immunosuppressant Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Organ Transplant Immunosuppressant Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Organ Transplant Immunosuppressant Drugs Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Organ Transplant Immunosuppressant Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Organ Transplant Immunosuppressant Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Organ Transplant Immunosuppressant Drugs Overall Market Size
2.1 Global Organ Transplant Immunosuppressant Drugs Market Size: 2022 VS 2029
2.2 Global Organ Transplant Immunosuppressant Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Organ Transplant Immunosuppressant Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Organ Transplant Immunosuppressant Drugs Players in Global Market
3.2 Top Global Organ Transplant Immunosuppressant Drugs Companies Ranked by Revenue
3.3 Global Organ Transplant Immunosuppressant Drugs Revenue by Companies
3.4 Global Organ Transplant Immunosuppressant Drugs Sales by Companies
3.5 Global Organ Transplant Immunosuppressant Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Organ Transplant Immunosuppressant Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Organ Transplant Immunosuppressant Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Organ Transplant Immunosuppressant Drugs Players in Global Market
3.8.1 List of Global Tier 1 Organ Transplant Immunosuppressant Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Organ Transplant Immunosuppressant Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Organ Transplant Immunosuppressant Drugs Market Size Markets, 2022 & 2029
4.1.2 Antibodies
4.1.3 Antiproliferative Agents
4.1.4 Calcineurin Inhibitors
4.1.5 mTOR Inhibitors
4.1.6 Steroids
4.2 By Type - Global Organ Transplant Immunosuppressant Drugs Revenue & Forecasts
4.2.1 By Type - Global Organ Transplant Immunosuppressant Drugs Revenue, 2018-2023
4.2.2 By Type - Global Organ Transplant Immunosuppressant Drugs Revenue, 2024-2029
4.2.3 By Type - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Organ Transplant Immunosuppressant Drugs Sales & Forecasts
4.3.1 By Type - Global Organ Transplant Immunosuppressant Drugs Sales, 2018-2023
4.3.2 By Type - Global Organ Transplant Immunosuppressant Drugs Sales, 2024-2029
4.3.3 By Type - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Organ Transplant Immunosuppressant Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Organ Transplant Immunosuppressant Drugs Market Size, 2022 & 2029
5.1.2 Bone Marrow Transplant
5.1.3 Heart Transplant
5.1.4 Kidney Transplant
5.1.5 Liver Transplant
5.1.6 Lung Transplant
5.2 By Application - Global Organ Transplant Immunosuppressant Drugs Revenue & Forecasts
5.2.1 By Application - Global Organ Transplant Immunosuppressant Drugs Revenue, 2018-2023
5.2.2 By Application - Global Organ Transplant Immunosuppressant Drugs Revenue, 2024-2029
5.2.3 By Application - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Organ Transplant Immunosuppressant Drugs Sales & Forecasts
5.3.1 By Application - Global Organ Transplant Immunosuppressant Drugs Sales, 2018-2023
5.3.2 By Application - Global Organ Transplant Immunosuppressant Drugs Sales, 2024-2029
5.3.3 By Application - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Organ Transplant Immunosuppressant Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Organ Transplant Immunosuppressant Drugs Market Size, 2022 & 2029
6.2 By Region - Global Organ Transplant Immunosuppressant Drugs Revenue & Forecasts
6.2.1 By Region - Global Organ Transplant Immunosuppressant Drugs Revenue, 2018-2023
6.2.2 By Region - Global Organ Transplant Immunosuppressant Drugs Revenue, 2024-2029
6.2.3 By Region - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Organ Transplant Immunosuppressant Drugs Sales & Forecasts
6.3.1 By Region - Global Organ Transplant Immunosuppressant Drugs Sales, 2018-2023
6.3.2 By Region - Global Organ Transplant Immunosuppressant Drugs Sales, 2024-2029
6.3.3 By Region - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029
6.4.2 By Country - North America Organ Transplant Immunosuppressant Drugs Sales, 2018-2029
6.4.3 US Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.4.4 Canada Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.4.5 Mexico Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Organ Transplant Immunosuppressant Drugs Sales, 2018-2029
6.5.3 Germany Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.4 France Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.5 U.K. Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.6 Italy Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.7 Russia Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.9 Benelux Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Organ Transplant Immunosuppressant Drugs Sales, 2018-2029
6.6.3 China Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.6.4 Japan Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.6.5 South Korea Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.6.7 India Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029
6.7.2 By Country - South America Organ Transplant Immunosuppressant Drugs Sales, 2018-2029
6.7.3 Brazil Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.7.4 Argentina Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales, 2018-2029
6.8.3 Turkey Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.8.4 Israel Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.8.6 UAE Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.1.4 Roche Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.2.4 Sanofi Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Astellas Pharma, Inc.
7.3.1 Astellas Pharma, Inc. Company Summary
7.3.2 Astellas Pharma, Inc. Business Overview
7.3.3 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.3.4 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Astellas Pharma, Inc. Key News & Latest Developments
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Company Summary
7.4.2 GlaxoSmithKline plc Business Overview
7.4.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.4.4 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline plc Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.5.4 Novartis AG Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Pfizer, Inc.
7.6.1 Pfizer, Inc. Company Summary
7.6.2 Pfizer, Inc. Business Overview
7.6.3 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.6.4 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer, Inc. Key News & Latest Developments
7.7 Veloxis Pharmaceuticals
7.7.1 Veloxis Pharmaceuticals Company Summary
7.7.2 Veloxis Pharmaceuticals Business Overview
7.7.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.7.4 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Veloxis Pharmaceuticals Key News & Latest Developments
8 Global Organ Transplant Immunosuppressant Drugs Production Capacity, Analysis
8.1 Global Organ Transplant Immunosuppressant Drugs Production Capacity, 2018-2029
8.2 Organ Transplant Immunosuppressant Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Organ Transplant Immunosuppressant Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Organ Transplant Immunosuppressant Drugs Supply Chain Analysis
10.1 Organ Transplant Immunosuppressant Drugs Industry Value Chain
10.2 Organ Transplant Immunosuppressant Drugs Upstream Market
10.3 Organ Transplant Immunosuppressant Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Organ Transplant Immunosuppressant Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Organ Transplant Immunosuppressant Drugs in Global Market
Table 2. Top Organ Transplant Immunosuppressant Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Organ Transplant Immunosuppressant Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Organ Transplant Immunosuppressant Drugs Sales by Companies, (K Doses), 2018-2023
Table 6. Global Organ Transplant Immunosuppressant Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Organ Transplant Immunosuppressant Drugs Price (2018-2023) & (USD/ Dose)
Table 8. Global Manufacturers Organ Transplant Immunosuppressant Drugs Product Type
Table 9. List of Global Tier 1 Organ Transplant Immunosuppressant Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Organ Transplant Immunosuppressant Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2018-2023
Table 15. By Type - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2024-2029
Table 16. By Application - Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2018-2023
Table 20. By Application - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2024-2029
Table 21. By Region - Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2018-2023
Table 25. By Region - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2024-2029
Table 26. By Country - North America Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2018-2023
Table 29. By Country - North America Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2024-2029
Table 30. By Country - Europe Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2024-2029
Table 34. By Region - Asia Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2024-2029
Table 38. By Country - South America Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2018-2023
Table 41. By Country - South America Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2024-2029
Table 42. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2024-2029
Table 46. Roche Company Summary
Table 47. Roche Organ Transplant Immunosuppressant Drugs Product Offerings
Table 48. Roche Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Organ Transplant Immunosuppressant Drugs Product Offerings
Table 52. Sanofi Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Astellas Pharma, Inc. Company Summary
Table 55. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Product Offerings
Table 56. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 57. Astellas Pharma, Inc. Key News & Latest Developments
Table 58. GlaxoSmithKline plc Company Summary
Table 59. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product Offerings
Table 60. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 61. GlaxoSmithKline plc Key News & Latest Developments
Table 62. Novartis AG Company Summary
Table 63. Novartis AG Organ Transplant Immunosuppressant Drugs Product Offerings
Table 64. Novartis AG Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 65. Novartis AG Key News & Latest Developments
Table 66. Pfizer, Inc. Company Summary
Table 67. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Product Offerings
Table 68. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 69. Pfizer, Inc. Key News & Latest Developments
Table 70. Veloxis Pharmaceuticals Company Summary
Table 71. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product Offerings
Table 72. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 73. Veloxis Pharmaceuticals Key News & Latest Developments
Table 74. Organ Transplant Immunosuppressant Drugs Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 75. Global Organ Transplant Immunosuppressant Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Organ Transplant Immunosuppressant Drugs Production by Region, 2018-2023 (K Doses)
Table 77. Global Organ Transplant Immunosuppressant Drugs Production by Region, 2024-2029 (K Doses)
Table 78. Organ Transplant Immunosuppressant Drugs Market Opportunities & Trends in Global Market
Table 79. Organ Transplant Immunosuppressant Drugs Market Drivers in Global Market
Table 80. Organ Transplant Immunosuppressant Drugs Market Restraints in Global Market
Table 81. Organ Transplant Immunosuppressant Drugs Raw Materials
Table 82. Organ Transplant Immunosuppressant Drugs Raw Materials Suppliers in Global Market
Table 83. Typical Organ Transplant Immunosuppressant Drugs Downstream
Table 84. Organ Transplant Immunosuppressant Drugs Downstream Clients in Global Market
Table 85. Organ Transplant Immunosuppressant Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Organ Transplant Immunosuppressant Drugs Segment by Type in 2022
Figure 2. Organ Transplant Immunosuppressant Drugs Segment by Application in 2022
Figure 3. Global Organ Transplant Immunosuppressant Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Organ Transplant Immunosuppressant Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Organ Transplant Immunosuppressant Drugs Sales in Global Market: 2018-2029 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Organ Transplant Immunosuppressant Drugs Revenue in 2022
Figure 9. By Type - Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose), 2018-2029
Figure 13. By Application - Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose), 2018-2029
Figure 17. By Region - Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 23. US Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 28. Germany Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 37. China Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Organ Transplant Immunosuppressant Drugs Production Capacity (K Doses), 2018-2029
Figure 53. The Percentage of Production Organ Transplant Immunosuppressant Drugs by Region, 2022 VS 2029
Figure 54. Organ Transplant Immunosuppressant Drugs Industry Value Chain
Figure 55. Marketing Channels
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
